Yearly Archives: 2011
Taylor Weber lies belly-down on the carpet of the Parkway Plaza Hotel, aiming an electronic rifle across a nearly empty hallway.
He props himself on his elbows and steadies the weapon. His target is 10 meters away — a gray box with five bull’s-eyes, each about the size of a golf ball.
There’s no shot when he pulls the trigger. Instead, a robotic voice with a Finnish accent speaks from a laptop to Weber’s right.
“You hit,” it says. “6.29 o’clock.”
Weber’s empty wheelchair sits several feet away. Behind it, a small group of athletes kill time by checking cell phones and chatting with one another.
For patients paralyzed by spinal cord injuries, Geron Corp.’s stem cell research was the shining hope.
The biotech firm showered scientists with millions of dollars to develop a treatment to reverse spinal damage. The therapy was the first treatment derived from embryonic stem cells to be cleared by the Food and Drug Administration for testing in humans.
But last week, Geron abruptly pulled the plug on its pioneering trial and the rest of its stem cell business, including early work on treatments for heart ailments, diabetes and other diseases. Pursuing futuristic cures through regenerative medicine was financially riskier than focusing on the company’s two cancer drugs, which were further along in development, company executives said.
People who had pinned their hopes on stem cells reacted with dismay.
For Laurie Kammer, Long Process of Healing is Well Under Way
Laurie Kammer, 27, is a daughter, a sister, a dancer, a ukulele player, a graphic artist, a young woman and a friend to many here in town, where she grew up and went to high school, graduating in 2003.
Since June, Laurie has also been paralyzed from the waist down after she fell from a tree in New Jersey.
After graduating from Eastern Connecticut State University with a degree in graphic design, Laurie had moved to New Jersey in 2009 to live with her brother, John, and his wife, Maria. She worked as a nanny for the couple’s two children.
This past summer, on June 9, she and a friend were in a tree house. They were about 15 feet up, she said, when a board she was standing on collapsed.
(Medical Xpress) — The Stanford University School of Medicine and Santa Clara Valley Medical Center treated the fifth patient in the Geron Corp-sponsored trial of a human embryonic-stem-cell-derived treatment for severe spinal cord injury on Nov. 16.
The patient, who is the second to be treated at Stanford and SCVMC, was enrolled in the trial before Geron announced on Nov. 14 that it was discontinuing the trial. The patient elected to undergo the procedure after being informed of the trial’s status.
Queensland University of Technology (QUT) researchers have developed a promising new treatment for spinal cord injury in animals, which could eventually prevent paralysis in thousands of people worldwide every year.
Dr Ben Goss, from the Institute for Health and Biomedical Innovation (IHBI) at QUT, is part of a research team investigating how to prevent the spinal cord from degenerating after an injury.
“The initial injury to the spinal cord is much like a bruise,” he said.
“However, unlike ordinary bruises the spinal cord has a persistent inflammatory response that leads to further damage.
Spinal cord injury is one of the world’s major unsolved health-care challenges, affecting not only the individuals who live with it but also their families. It requires specialized treatment and long-term care, amounting to billions of dollars annually in Canada. As Tracy’s story illustrates, once surgery and rehabilitation are complete, the challenges faced can be relentless – from painful secondary health complications to multiple barriers to reintegration.
AMS Vans sells and rents new and used handicap accessible vans for some of the lowest prices online. AMS Vans delivers handicap vans nationwide. Browse over 150 wheelchair vans on their website or in their indoor showroom in Atlanta, Georgia. Other services they provide include van conversions, handicap van classifieds, adapted vehicle mobility equipment, trade-ins, and more.
We don’t often realize it, but all fashion is predicated upon human beings’ predilection for prostheses and augmentations. All clothing, bags, and shoes are augmentation to our body, skin, and feet allowing us to deal with non-tropical climates, to carry large amounts of stuff, and to deal with harsh or unforgiving terrain. If humans hadn’t already modified ourselves, the only fashion we’d have is hairstyle.
Eyeglasses and contact lenses are one of the most prolific forms of medical augmentation on the planet. In many industrialized modern cultures, eyeglasses and contacts are also a major element of fashion. Thin, small glasses are out of fashion; big, chunky frames with large lenses are in. Tomorrow it might be different. But in every case, you have glasses because you have a medical problem that needs fixing.
The Injury Co-Op is a comprehensive resource for catastrophic injury survivors and their families who are seeking guidance on the journey to recovery. Created by fellow survivors, the Injury Co-Op is dedicated to providing education, support and hope for a better tomorrow.
Located in Central Florida, the Injury Co-Op has a Peer Mentor Program matching successful injury survivors with newly injured persons. Also, the Co-Op has a Care Program with various initiatives to offer comfort and aid to local families who have recently had a loved one sustain a traumatic injury.”
The company conducting the world’s first clinical trial of a therapy using human embryonic stem cells said on Monday that it was halting that trial and leaving the stem cell business entirely.
The company, Geron, said that its move did not reflect a lack of promise for the controversial field. Rather, it said, with money scarce, it had decided to focus on its experimental cancer therapies, which are further along in development.
“I deeply believe in the promise of stem cells,” John A. Scarlett, the chief executive of Geron, said in an interview. “I don’t think that promise is in any way, shape or form changed by what we’re doing.”